AGM-130
AGM-130 is a cyclin-dependent kinase (CDK) inhibitor. AGM-130 exhibits antitumor activity[1].
Product Specifications
CAS Number
1459216-10-4
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C(N1)/C(C2=C1C=CC([N+]([O-])=O)=C2)=C3/C(C(C=C(O)C=C4)=C4N3)=N/O
Molecular Formula
C16H10N4O5
Molecular Weight
338.27
References & Citations
[1]Park WS, et al. Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients. Cancer Chemother Pharmacol. 2017 Aug;80 (2) :363-369.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP56787_P050-Biotin 100 µL
Memo1 Antibody - C-terminal region : Biotin (ARP56787_P050-Biotin)
Sign In for Pricing
View Details 
SPACA7-8603M 50 µg
Recombinant Mouse SPACA7 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details